Index | microbiology Webinars 2020

Theme: Microbiota: a Microscopic Shield Against COVID-19

Microbe Infections 2020

Microbe Infections 2020

Conference Series invites all the participants from all over the world to attend World Congress on “Microbiology and Rare Infectious Diseases”(MICROBE INFECTIONS 2020) during June 25-26, 2020 which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

The aim of our conference is to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. Conference Series gathers renowned Physicians, Pharmacists, Scientists, Microbiologists, Young Researchers, Healthcare Industrial Delegates and Talented Student Communities in the field of Medical Science under a single roof where networking and global partnering happens for the acceleration of future research.

About MICROBE INFECTIONS 2020

Conference Series through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Conference series LLC hosts over 700 leading-edge peer reviewed Open Access journals and has organized over 3000 scientific conferences all over the world.

Conference Series welcomes all Physicians, Pharmacists, Scientists, Young Researchers, Healthcare Industrial Delegates and Talented Student Communities in the field of Microbiology Department to attend this World Congress on Microbiology and Rare infectious Diseases, where all the aspects of applied microbiology and all the infections related to microbes will be discussed under single roof. Microbe Infections 2020 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

Why to Attend MICROBE INFECTIONS 2020?

Microbes Infection 2020 highlights the theme “Discovering the New Challenges in Microbiology” With members from around the world focused on learning about Microbiology and Rare Infectious Diseases and its advances in innovation of Pharmaceutical, Food, Brewing Industries, Clinical Healthcare Systems , Hospitals and Research Organizations. This is the best opportunity to reach the largest assemblage of participants from the Microbiology community conduct presentations, distribute information, meet with current and potential scientists, make a splash with new Medical techniques in recent trends, and receive name recognition at this 2-day event. World-renowned speakers, scientists, doctors, the most recent innovations, developments, and the newest updates in MICROBE INFECTIONS 2020 are importance of this conference.

Microbiology

Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi and protozoa. This discipline includes fundamental research on the biochemistry, physiology, cell biology, ecology, evolution and clinical aspects of microorganisms, including the host response to these agents. The Research person in microbiology is named as Microbiologists. Microbiologists study microbes (includes bacteria, archaea, viruses, fungi, prions, protozoa and algae).Some of the Microbes are play keyrole in nutrient cycle and for the production of human beneficial product such as medicine, antibiotic, vaccines and biotechnological engineering product.

ASIA-PACIFIC:

Pan-Pacific Surgical Association Congress, Federation of Asia-Pacific Microbiology Societies, Malaysian Society of Infectious Diseases, Singapore Society for Microbiology and Biotechnology, Malaysian Society for Microbiology, Asia Pacific Society of Clinical Microbiology and Infection, The Philippine Society for Microbiology, Asia Pacific Society for Marine Biotechnology, Committee of Asia Pacific Electron Microscopy Societies, Federation of Asia Pacific Microbiological Societies, International Union of Microbiological Societies; Singapore National Academy of Sciences, Japanese Society of Microbial Ecology

USA:

Federation of American societies for experimental biology, American society for microbiology, Society for industrial Microbiology and biotechnology, Society for Applied Microbiology, Society for industrial microbiology, International Union of microbiological societies, Southern California Branch of the American Society for Microbiology, Southeastern association for clinical microbiology, Association of medical school microbiology and immunology chairs.

EUROPE:

Italian Society of Agro-Food and Microbial Biotechnologies, Federation of European Microbiological Societies, European Molecular Biology Organization, Society for Applied Microbiology, Swiss Society for Infectious Disease, European Molecular Biology Organization, International Center for Genetic Engineering and Biotechnology, Federation of European Microbiological Societies, European Society for Clinical Virology, International Union of Microbiological Societies.

Microbes

In microbiology we are study about the microscopic organism or unicellular organism such as Bacteira, Viruses, Fungi and others which are named as microbes. These microbes play key roles in nutrient cycling, biodegradation/biodeterioration, climate change, food spoilage, the cause and control of disease, and biotechnology. Thanks to their versatility, microbes can be put to work in many ways: making life-saving drugs, the manufacture of biofuels, cleaning up pollution, and producing/processing food and drink.

There are also some Infectious agents come in many shapes and sizes. Bacteria and protozoans are microscopic one-celled organisms, while viruses are even smaller. Fungi grow like plants, and helminths resemble worms.

ASIA-PACIFIC:

USA:

EUROPE:

Infectious Diseases Research

Infectious diseases – also known as contagious diseases, transmissible diseases or communicable diseases – are caused by pathogenic microorganisms that infect a host organism and can be spread, directly or indirectly, from one organism to another.

Infectious disease research has the potential for broad application because everyone, in every area of the world, is infected by microbes at some point in his or her life.

Microbes are simple organisms capable of rapid genetic mutation. Many evolve into new strains that resist available therapies. The ease of international travel and an increasing world population facilitate problems associated with rapid microbial evolution.

ASIA-PACIFIC:

USA:

EUROPE:

Infectious Microbes and Diseases

Microbes that cause disease are called pathogens. A pathogen is a micro-organism that has the potential to cause disease.

An infection is the invasion and multiplication of pathogenic microbes in an individual or population. Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi or parasite.

Disease is when the infection causes damage to the individual’s vital functions or systems.

Pathogens cause disease either by disrupting the bodies normal processes and/or stimulating the immune system to produce a defensive response, resulting in high fever, inflammation? and other symptoms. Microbes can enter the body through the four sites listed below:

Respiratory tract.

Gastrointestinal tract

Urogenital tract breaks in the skin surface.

ASIA-PACIFIC:

USA:

EUROPE:

Viral infection diseases

Viruses are very tiny germs. They are made of genetic material inside of a protein coating. Viruses cause familiar infectious diseases such as the common cold, flu and warts. They also cause severe illnesses such as HIV/AIDS, smallpox, and Ebola.

Viruses are like hijackers. They invade living, normal cells and use those cells to multiply and produce other viruses like themselves. This can kill, damage, or change the cells and make you sick. Different viruses attack certain cells in your body such as your liver, respiratory system, or blood.

A viral disease is any illness or health condition caused by a virus. Read on to learn more about some of the main types of viral diseases:

Not all viral diseases are contagious. This means they aren’t always spread from person to person. But many of them are. Common examples of contagious viral diseases include the flu, the common cold, HIV, and herpes.

The current outbreak of viral infection diseases is Coronavirus disease (COVID-19)

Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans.

ASIA-PACIFIC:

USA:

EUROPE:

Bacterial infection diseases

A bacterial infection is a proliferation of a harmful strain of bacteria on or inside the body. Bacteria can infect any area of the body. Pneumonia, meningitis, and food poisoning are just a few illnesses that may be caused by harmful bacteria. Bacteria come in three basic shapes: rod-shaped (bacilli), spherical (cocci), or helical (spirilla). Bacteria may also be classified as gram-positive or gram-negative. Gram-positive bacteria have a thick cell wall while gram-negative bacteria do not. Gram staining, bacterial culture with antibiotic sensitivity determination and other tests are used to identify bacterial strains and help determine the appropriate course of treatment.

ASIA-PACIFIC:

USA:

EUROPE:

Fungal infection

Fungal infections are common throughout much of the natural world. In humans, fungal infections occur when an invading fungus takes over an area of the body and is too much for the immune system to handle.

Fungi can live in the air, soil, water, and plants. There are also some fungi that live naturally in the human body.

Like many microbes, there are helpful fungi and harmful fungi. When harmful fungi invade the body, they can be difficult to kill, as they can survive in the environment and re-infect the person trying to get better.

Fungal infections are silent killers, and cause misery to millions. More die of fungal diseases than either TB or malaria. After headaches and rotten teeth, skin fungal infections are the commonest diseases on Earth. Serious fungal infections afflict the most economically productive, especially in TB, AIDS and cancer patients, having a disproportionate impact on economies.

The common symptoms for fungal infections are,

skin changes, including red and possibly cracking or peeling skin

itching

ASIA-PACIFIC:

USA:

EUROPE:

Parasitic infection diseases

Parasites are living things that use other living things - like your body - for food and a place to live. You can get them from contaminated food or water, a bug bite, or sexual contact. Some parasitic diseases are easily treated and some are not.

Parasites range in size from tiny, one-celled organisms called protozoa to worms that can be seen with the naked eye. Some parasitic diseases occur in the United States. Contaminated water supplies can lead to Giardia infections. Cats can transmit toxoplasmosis, which is dangerous for pregnant women. Others, like malaria, are common in other parts of the world.

Of the several hundred known species of parasites, only small fractions are capable of causing disease in humans. Among them are the protozoans Entamoeba histolytica, which causes amebic dysentery and is acquired through the ingestion of food or water that has been contaminated by the feces of a human carrier of the infective organism, and the flagellated protozoans Trypanosoma brucei gambiense and T. brucei rhodesiense, which causes sleeping sickness (African trypanosomiasis) and is transmitted to humans through the bite of infected tsetse flies.

ASIA-PACIFIC:

USA:

EUROPE:

Microbiology research advancement

Male-killing bacteria linked to butterfly color changes

Like many poisonous animals, the African monarch butterfly's orange, white and black pattern warns predators that it is toxic. Warning patterns like this are usually consistent across individuals to help predators learn to avoid them. However, a recent study shows how a population of African monarch butterflies (Danaus chrysippus) breaks this rule and has highly variable warning patterns.

ASIA-PACIFIC:

USA:

EUROPE:

Antimicrobial Resistance

Antimicrobial resistance happens when microorganisms (such as bacteria, fungi, viruses, and parasites) change when they are exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals, antimalarials, and anthelmintics). Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.

New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases, resulting in prolonged illness, disability, and death.

Without effective antimicrobials for prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, diabetes management and major surgery (for example, caesarean sections or hip replacements) become very high risk.

Antimicrobial resistance increases the cost of health care with lengthier stays in hospitals and more intensive care required.

Antimicrobial resistance is putting the gains of the Millennium Development Goals at risk and endangers achievement of the Sustainable Development Goals.

Antimicrobial resistance occurs naturally over time, usually through genetic changes. However, the misuse and overuse of antimicrobials is accelerating this process. In many places, antibiotics are overused and misused in people and animals, and often given without professional oversight. Examples of misuse include when they are taken by people with viral infections like colds and flu, and when they are given as growth promoters in animals or used to prevent diseases in healthy animals.

ASIA-PACIFIC:

USA:

EUROPE:

Target Audience:

Directors, Board Members, Presidents, Vice Presidents
Deans and Head of the Departments
Business Entrepreneurs and Industrialists
Microbiologist
Virologists
Parasitologist
Bacteriologist
Pharmacists
Epidemiologists
Dermatologists
Neurologist
Ophthalmologist
Cardiologist
Infectious Diseases Researchers, Scientists, Faculties, Students
Infectious Diseases Associations and Societies
Medical Colleges, Hospitals & Labs
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies

Industry Insights

The global infectious diseases in vitro diagnostics market size was valued at USD 16.3 billion in 2019 and is projected to register a CAGR of 6.2% from 2019 to 2027. Increase in external funds for Research and Development (R&D) purposes and favorable government initiatives are some of the key growth drivers of the market for IVD infectious diseases.

Rapid rise of the global geriatric population is one of the key drivers for market growth as aging is directly proportional to several chronic diseases. According to the United Nations’ World Population Aging Report 2019, the number of elderly people aged 80 years and above-currently estimated at 143 million in 2019-is projected to triple by 2050 and would reach 426 million.

Increasing burden of target diseases, rising health awareness, and shift toward self-care clinical devices are projected to drive the market for IVD infectious diseases. Moreover, advancements in IVD kits with improved speed, sensitivity, and patient compliance is anticipated to increase the penetration of IVD kits for diagnosing infectious diseases.

Technological progress has led to the introduction of advanced IVD tools, such as mobile Real Time Polymerase Chain Reaction (qPCR), in the market for IVD infectious diseases. The dynamics of the market drive the adoption of technologies, most prominently self-testing tools for infectious diseases. However, expenses associated with IVD diagnostic tests and lack of stringent regulatory framework are inhibiting market growth.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

Competitive benchmarking
Market forecasts
Company market shares
Market opportunities
Latest trends & dynamics

Product Insights

Reagents dominated the product segment in 2019. Rise in the number of R&D initiatives associated with molecular diagnostic tools and increasing demand for self-test and point of care products are expected to maintain the market position of this segment through the forecast period. The segment is estimated to exhibit a CAGR of 6.5% over the forecast period.

Analytical instruments include machines and equipment that enable process automation as well as combine samples and reagents. Commercialized IVD kits assist in disease diagnosis using PCR for detection and quantification of infectious microorganisms, viral load, and blood antigens.

Application Insights

IVD find wide-spread application in the diagnosis and testing of multiple infectious diseases such as Methicillin-resistant Staphylococcus aureus (MRSA), HIV, streptococcal infections, hepatitis, and influenza. HIV tests accounted for the largest share of the infectious diseases in vitro diagnostics market in 2019. This is attributed to the rapidly escalating disease burden and high unmet medical needs in emerging economies.

Tuberculosis (TB) and drug-resistant TB are expected to demonstrate steady growth over the next few years. It is estimated that HIV-infected people are 26 to 31 times more likely to suffer from TB due to a compromised immune system. Furthermore, key diagnostic manufacturers are constantly updating the range of diagnostic tests, particularly IVD kits, for their instruments through several R&D initiatives and investments in clinical trials. This leads to the development of affordable and efficient diagnostic kits to address the burden of infectious diseases.

End-use Insights

Central laboratories emerged as the largest end-use segment in 2019, driven primarily by the large volume of tests carried out in central laboratories. The point of care (PoC) segment is anticipated to exhibit the highest CAGR over the forecast period owing to increasing initiatives intended to reduce hospital stays to limit healthcare expenditure and growing need for rapid diagnosis for detecting infectious diseases.

Increasing patient demand for bedside care, supported by rising adoption of decentralized healthcare establishments and flourishing home healthcare sector, is also driving the market growth. Moreover, increasing adoption of self-care or OTC diagnostics in developing markets such as China and India, growing consumer awareness, and advancements in healthcare infrastructure are driving the demand for IVD kits for the detection of infectious diseases.

Technology Insights

Based on technology, immunochemistry generated the highest revenue in 2019, followed closely by molecular diagnostics. However, molecular diagnostics is estimated to be the largest segment by 2027 owing to the increasing penetration and growing demand for sensitive, accurate, and rapid new-age devices such as advanced IVD kits for diagnosing infectious diseases. Moreover, microbiology is expected to demonstrate moderate growth, supported by new-age molecular diagnostic techniques replacing traditional methods.

Molecular diagnostics renders accurate and fast results in the IVD field, thus playing an imperative role in the diagnosis and treatment of infectious diseases. Moreover, rising burden of hospital-acquired infections is expected to drive the demand for molecular IVD kits. Furthermore, growing burden of sexually transmitted diseases, especially HPV and HIV, is likely to increase the target patient base, subsequently driving the demand for IVD tools for detecting infectious diseases.

Regional Insights

North America accounted for a share of a little over 44.0% of the global market in 2019, and this trend is expected to continue through the forecast period. This is attributed to high awareness levels of practitioners and patients, proactive government initiatives, and presence of sophisticated healthcare infrastructure.

Asia Pacific is expected to register the highest CAGR from 2019 to 2027, fueled by the presence of favorable government initiatives for infectious disease testing, high unmet medical needs, economic development and consequent rise in disposable income, and increase in healthcare spending in emerging countries such as China, India, and South Korea.

Infectious Diseases In Vitro Diagnostics Market Share Insights

Key players in the market include bioMérieux SA; BD; Abbott; Alere Inc.; Quidel Corporation; F. Hoffmann-La Roche Ltd.; Orasure Technologies, Inc.; Cepheid; Hologic Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; and Siemens Healthcare GmbH.

Increasing instances of strategic collaborations, aimed at enhancement of R&D for improved therapeutics, has created abundant growth opportunities in the market. Technological progress in diagnostic platforms is likely to introduce advanced and upgraded versions of IVD tools for the advanced treatment of infectious diseases.

Report Scope

Attribute	Details
Base year for estimation	2019
Actual estimates/Historical data	2015 - 2018
Forecast period	2020 - 2027
Market representation	Revenue in USD Million and CAGR from 2019 to 2027
Regional scope	North America, Europe, Latin America, Asia Pacific, Middle East & Africa
Country scope	U.S., Canada, Germany, U.K., Spain, France, Italy, Brazil, Mexico, Argentina, Japan, China, India, South Korea, Australia, South Africa, Saudi Arabia, UAE
Report coverage	Revenue forecast, competitive landscape, growth factors, and trends
15% free customization scope (equivalent to 5 analysts working days)	If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2015 to 2027. For the purpose of this study, Grand View Research has segmented the global infectious diseases in vitro diagnostics market report on the basis of product, technology, application, end use, and region:

Product Outlook (Revenue, USD Million, 2015 - 2027)
- Instruments
- Reagents
- Software
Technology Outlook (Revenue, USD Million, 2015 - 2027)
- Immunochemistry
- Molecular Diagnostics
- Microbiology
- Others
Application Outlook (Revenue, USD Million, 2015 - 2027)
- MRSA
- Streptococcus
- Clostridium difficile
- VRE
- CRE
- Respiratory Virus
- Candida
- TB and Drug-resistant TB
- Gastro-intestinal Panel Testing
- Chlamydia
- Gonorrhea
- HPV
- HIV
- Hepatitis C
- Hepatitis B
- Others
End-use Outlook (Revenue, USD Million, 2015 - 2027)
- Point of Care
- Central Laboratories
Regional Outlook (Revenue, USD Million, 2015 - 2027)
- North America
  - U.S.
  - Canada
- Europe
  - U.K.
  - Germany
  - Spain
  - France
  - Italy
- Latin America
  - Brazil
  - Mexico
  - Argentina
- Asia Pacific
  - Japan
  - China
  - India
  - South Korea
  - Australia
- Middle East & Africa
  - South Africa
  - Saudi Arabia
  - UAE

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 25-26, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

World Congress on Microbiology and Rare Infectious Diseases June 25-26, 2020 Osaka, Japan

Recommended Global Microbiology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Microbe Infections 2020

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues